Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04374630
Title Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian (PROFECTA-II)
Acronym PROFECTA-II
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Laekna Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Associates Phoenix Arizona 85016 United States Details
Arizona Oncology Tucson Arizona 85711 United States Details
Highlands Oncology Group Rogers Arkansas 72758 United States Details
Gynecology Oncology Associates Newport Beach Newport Beach California 92663 United States Details
Rocky Mountain Cancer Centers Littleton Colorado 80120 United States Details
Kapiolani Medical Center for Women and Children Honolulu Hawaii 96826 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Women's Cancer Care Covington Louisiana 70433 United States Details
Tufts Medical Center Boston Massachusetts 02111 United States Details
University of Massachusetts Worcester Massachusetts 01605 United States Details
Nebraska Methodist Hospital Omaha Nebraska 68114 United States Details
MD Anderson Cancer Center at Cooper Camden New Jersey 08103 United States Details
Holy Name Medical Center Teaneck New Jersey 07666 United States Details
Southwest Women's Oncology Group Albuquerque New Mexico 87106 United States Details
Montefiore Medical Center Bronx New York 10467 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45219 United States Details
OHCare Oncology Hematology Care (OHC), Inc. - Kenwood Office Cincinnati Ohio 45242 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Abington Memorial Hospital Willow Grove Pennsylvania 19090 United States Details
Women & Infants Hospital of Rhode Island Providence Rhode Island 02905 United States Details
Texas Oncology Austin Texas 78731 United States Details
Texas Oncology Fort Worth Texas 76104 United States Details
Houston Methodist Hospital Houston Texas 77030 United States Details
University of Texas Health Science Center at Houston Houston Texas 77030 United States Details
USO Texas Oncology Longview Texas 75601 United States Details
US Texas Oncology San Antonio Texas 78240 United States Details
Baylor Scott & White Medical Center Temple Texas 76508 United States Details
Texas Oncology The Woodlands Texas 77380 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
University of Washington/Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Beijing Obstetrics & Gynecology Hospital, Capital Medical University Beijing China Details
Cancer Hospital Chinese Academy of Medical Sciences Beijing China Details
Peking University Cancer Hospital Beijing China Details
Chongqing University Cancer Hospital Chongqing China Details
Sun Yat-sen University Cancer Center Guangdong China Details
Harbin Medical University Cancer Hospital Heilongjiang China Details
Henan Cancer Hospital Henan China Details
Hubei Cancer Hospital Hubei China Details
Hunan Cancer Hospital Hunan China Details
Jilin Cancer Hospital Jilin China Details
Liaoning Cancer Hospital Liaoyang China Details
Qilu Hospital of Shandong University Shandong China Details
Obstetrics & Gynecology Hospital of Fudan University Shanghai China Details
Zhongshan Hospital affiliated to Fudan University Shanghai China Details
West China Second University Hospital,Sichuan University Sichuan China Details
The Second Hospital of Tianjin Medical University Tianjin China Details
Women's Hospital school of medicine Zhejiang University Zhejiang China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field